Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate and gamma-aminobutyric acid (GABA) receptors are the primary mediators of excitatory and inhibitory neurotransmission in the vertebrate central nervous system, respectively. Glutamate receptors are divided into ionotropic receptors (NMDA, AMPA, and kainate), which are ligand-gated ion channels, and metabotropic receptors (mGluRs), which are G protein-coupled receptors (StatPearls, 2023). GABA receptors are similarly divided into the ionotropic GABA-A receptor, which primarily conducts chloride ions to hyperpolarize neurons, and the metabotropic GABA-B receptor (NIH, 2022). The balance between these two systems, often referred to as the E/I balance, is critical for maintaining physiological brain states and supporting cognitive functions like learning and memory. Dysregulation of this balance is a hallmark of numerous neurological and psychiatric conditions, including epilepsy, anxiety disorders, and neurodegenerative diseases (PubMed, 2021). Therapeutic strategies involve modulating these receptors using agonists, antagonists, or allosteric modulators to restore normal signaling, though such interventions must carefully manage risks like sedation or excitotoxicity (PubChem, 2024).
Modulation of excitatory and inhibitory synaptic transmission through agonism, antagonism, or allosteric regulation of ionotropic and metabotropic receptors (StatPearls, 2023; PubChem, 2024).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate and gamma-aminobutyric acid receptors (GluR/GABAR).